Singapore: AbbVie, a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott, h...
Singapore: Australian scientists have developed a new test that can detect bird flu mutation by distinguishing between b...
Singapore: WHO, in consultation with over 70 experts, is assessing the status of two Ebola vaccine candidates for their ...
Singapore: Global biopharmaceutical firm, Roche, is all set to acquire Santaris Pharma, a Denmark based biopharmaceutica...
Singapore: China-based Beike Biotechnology has recieved Chinese Food and Drug Administration (CFDA) nod for filing the a...
Singapore: Danish firm, Mirrx Therapeutics and Australia's Centenary Institute of Cancer Medicine and Cell Biology has f...
Singapore: From September 29-30, 2014, WHO organized an expert consultation to assess the groundwork of ebola vaccine de...
Singapore: Boehringer Ingelheim plans to establish a new large-scale biopharmaceutical production facility for active in...
Singapore: Guangdong subsidiary of China Cord Blood Corporation, a provider of cord blood collection, laboratory testing...
Singapore: Asthma treatment market value will grow from approximately USD15.9 billion in 2013, across eight major countr...
Singapore: A study led by the National University of Singapore (NUS) has found that attaching chemotherapy drug Epirubic...
Singapore: India-based Zydus Cadila has launched the biosimilar of Adalimumab, indicated for the treatment of auto immun...
Singapore: China Biologic Products, China-based biopharmaceutical company, has received China Food and Drug Administrati...
Singapore: Researchers at the National Institute of Health (NIH) have found that immune responses instigated by MERS inf...
Singapore: Under the terms of the agreement, Sanofi will have access to Boehringer Ingelheim's capabilities in Biberach ...
Singapore: Singapore Economic Development Board has invested in Rapid Micro Biosystems, a provider of automated, non-des...
Singapore: A*STAR scientists have identified the enzyme, telomerase, as a cause of chronic inflammation in human cancers...
Singapore: Genentech, a member of the Roche Group, plans to invest more than USD285 million for the expansion of its bio...
